<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSM563584"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563584"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563584"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/+</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563587"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563587"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563587"><item key="SAMPLE TYPE">tumors derived from Pax7-expressing cells in vivo</item><item key="GENOTYPE">Pax7CE/+;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563590"><item key="SAMPLE TYPE">tumors derived from CSM4B cells transformed in vitro</item><item key="GENOTYPE">R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563590"><item key="SAMPLE TYPE">tumors derived from CSM4B cells transformed in vitro</item><item key="GENOTYPE">R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563590"><item key="SAMPLE TYPE">tumors derived from CSM4B cells transformed in vitro</item><item key="GENOTYPE">R26-Cre-ERT2;LSL-KrasG12D/+;Trp53Fl/Fl</item><item key="ORGANISM PART">Tumor</item></item></item><item><item key="GSM563593"><item key="SAMPLE TYPE">normal muscle as control for myogenic tumors</item><item key="GENOTYPE">littermate control</item><item key="ORGANISM PART">muscle</item></item></item><item><item key="GSM563593"><item key="SAMPLE TYPE">normal muscle as control for myogenic tumors</item><item key="GENOTYPE">littermate control</item><item key="ORGANISM PART">muscle</item></item></item><item><item key="GSM563593"><item key="SAMPLE TYPE">normal muscle as control for myogenic tumors</item><item key="GENOTYPE">littermate control</item><item key="ORGANISM PART">muscle</item></item></item></item><item key="id">8495</item><item key="pop_total">0</item><item key="platform">8</item><item key="summary_wrapped">Mouse muscle stem cells, defined as Pax7+ satellite cells, can initiate rhabdomyosarcoma when transformed by oncogenic Kras and...</item><item key="geo_gse_id">E-GEOD-22798</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">3</item><item key="sample_count">12</item><item key="tags"><item>muscle</item><item>rhabdomyosarcoma</item><item>sarcoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">expression-data-from-pax7-satellite-cell-derived-t</item><item key="geo_id_plat">E-GEOD-22798_A-AFFY-36</item><item key="name">Expression data from Pax7+ satellite cell derived tumors in vitro and in vivo</item><item key="created">Nov.24, 2014</item><item key="summary">Mouse muscle stem cells, defined as Pax7+ satellite cells, can initiate rhabdomyosarcoma when transformed by oncogenic Kras and concomitant loss of p53. Mouse Pax7+ satellite cells were transformed in vitro and in vivo utilizing the Cre-ER/loxp system. We wanted to address two major questions: do the in vitro and in vivo tumors cluster together compared to another mouse to another mouse derived soft-tissue sarcoma AND which human soft-tissue sarcoma do the in vivo derived tumors resemble transcriptionally?  Therefore, tumors from cells transformed in vitro and tumors from mice that restrict the oncogenic lesions to Pax7+ satellite cells in vivo were compared to answer these two questions.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22798</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22798/samples/</item></data></biogps>
